FTC sues drug ‘gatekeepers’ over excessive insulin costs
The U.S. Federal Commerce Fee sued the nation’s three largest pharmacy profit managers on Friday, accusing them of steering diabetes sufferers towards higher-priced insulin to reap tens of millions of {dollars} in rebates from pharmaceutical firms. The case accuses UnitedHealth Group Inc’s Optum unit, CVS Well being Corp’s CVS Caremark and Cigna Corp’s Categorical Scripts of unfairly excluding
Read More